# Pilot Study of Raltegravir Lipodystrophy IISP

> **NCT01164605** · NA · UNKNOWN · sponsor: **Southern California Institute for Research and Education** · enrollment: 30 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01164605
- **Lead sponsor:** Southern California Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164605, "Pilot Study of Raltegravir Lipodystrophy IISP". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01164605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*